Display options
Cite
Augustyniak A, Stankiewicz A, Skrzydlewska E. The Influence of L-Carnitine on Oxidative Modification of LDL In Vitro. Toxicol Mech Methods. 2008;18(6):455-462doi: 10.1080/15376510701623508.
Augustyniak, A., Stankiewicz, A., & Skrzydlewska, E. (2008). The Influence of L-Carnitine on Oxidative Modification of LDL In Vitro. Toxicology mechanisms and methods, 18(6), 455-462. https://doi.org/10.1080/15376510701623508
Augustyniak, Agnieszka, et al. "The Influence of L-Carnitine on Oxidative Modification of LDL In Vitro." Toxicology mechanisms and methods vol. 18,6 (2008): 455-462. doi: https://doi.org/10.1080/15376510701623508
Augustyniak A, Stankiewicz A, Skrzydlewska E. The Influence of L-Carnitine on Oxidative Modification of LDL In Vitro. Toxicol Mech Methods. 2008 Jul;18(6):455-462. doi: 10.1080/15376510701623508. Epub 2008 Jun 23. PMID: 19696940; PMCID: PMC2728756.
Copy Download .nbib Format: NLM
Share it on

Toxicol Mech Methods. 2008 Jul;18(6):455-462. doi: 10.1080/15376510701623508. Epub 2008 Jun 23.

The Influence of L-Carnitine on Oxidative Modification of LDL In Vitro.

Toxicology mechanisms and methods

Agnieszka Augustyniak, Anna Stankiewicz, Elżbieta Skrzydlewska

Affiliations

  1. Department of Inorganic and Analytical Chemistry, Medical University of Bialystok, Mickiewicza 2a, Box 1415-230, Bialystok, Poland.

PMID: 19696940 PMCID: PMC2728756 DOI: 10.1080/15376510701623508

Abstract

Owing to their structure and function, low-density lipoproteins (LDLs) are particularly susceptible to the oxidative modifications. To prevent against oxidative modification of LDL, L-carnitine, with endogenous small water-soluble quaternary amine possessing antioxidative properties, was used. The aim of this paper was to prove the in vitro influence of L-carnitine on the degree of oxidative modification of the lipid part (estimated by conjugated dienes, lipid hydroperoxides, and malondialdehyde levels) and the protein part (estimated by dityrosine and tryptophan levels) of LDL native and oxidized by cooper ions. The level of lipophylic LDL antioxidant-alpha-tocopherol was also measured.Oxidation of LDL by Cu(2+) enhanced lipid peroxidation. That was manifested by a statistically significant increase in the content of malondialdehyde (threefold), conjugated dienes (up to about 30%), and lipid hydroperoxides (up to about 50%). Cu(2+) ions were also the cause of oxidative modifications of the protein part of LDLs. It was manifested by a significant increase in dityrosine (by about 50%), whereas the level of tryptophan was significantly decreased threefold in relation to native LDL. Incubation of LDL with Cu(2+) ions also caused a significant sixfold decrease of alpha-tocopherol content in oxidized LDL. However, L-carnitine caused a decrease in the level of conjugated dienes, lipid hydroperoxide, malondialdehyde, and dityrosine by about 20% to 30%, and a significant increase (by about 50%) in the content of tryptophan in comparison with oxidative LDL and in a smaller degree significant changes with native LDL. Additionally, L-carnitine caused a significant twofold increase in alpha-tocopherol content in oxidized LDL.The above results indicate that L-carnitine protects the lipid as well as protein part of LDL particles against oxidative modifications, and this natural antioxidant might be used to prevent against diseases of oxidative origin.

References

  1. J Lipid Res. 1993 Dec;34(12):2135-45 - PubMed
  2. J Chromatogr. 1979 Mar 1;162(3):408-13 - PubMed
  3. FASEB J. 1999 Jul;13(10):1113-20 - PubMed
  4. Acta Pharmacol Sin. 2004 Aug;25(8):1038-44 - PubMed
  5. J Chromatogr A. 1996 Apr 5;729(1-2):207-10 - PubMed
  6. Ann Nutr Metab. 2000;44(2):75-96 - PubMed
  7. J Lipid Res. 1970 Nov;11(6):583-95 - PubMed
  8. J Lipid Res. 1993 Jul;34(7):1209-17 - PubMed
  9. Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):594-602 - PubMed
  10. J Lipid Res. 2001 Oct;42(10):1664-70 - PubMed
  11. Drugs R D. 2003;4(3):141-7 - PubMed
  12. J Biol Chem. 1995 Mar 10;270(10):5158-63 - PubMed
  13. Reprod Biomed Online. 2004 Apr;8(4):376-84 - PubMed
  14. J Nat Prod. 2000 Jul;63(7):1035-42 - PubMed
  15. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
  16. J Nutr Biochem. 2001 May;12(5):254-257 - PubMed
  17. Life Sci. 2006 Jan 18;78(8):803-11 - PubMed
  18. Exp Gerontol. 2001 Nov;36(10):1713-26 - PubMed
  19. Free Radic Biol Med. 1999 Feb;26(3-4):463-71 - PubMed
  20. Int J Cardiol. 2006 Feb 8;107(1):54-60 - PubMed
  21. Exp Gerontol. 2005 Mar;40(3):129-35 - PubMed
  22. Neurochem Res. 1993 Nov;18(11):1157-62 - PubMed
  23. J Neurochem. 1988 Aug;51(2):621-3 - PubMed
  24. Methods Enzymol. 1984;105:331-7 - PubMed
  25. Atherosclerosis. 2000 Jan;148(1):67-73 - PubMed
  26. J Lipid Res. 1995 Nov;36(11):2383-93 - PubMed
  27. Clin Chim Acta. 2006 Jun;368(1-2):84-92 - PubMed
  28. J Biol Chem. 1997 Feb 7;272(6):3520-6 - PubMed
  29. J Physiol Pharmacol. 2004 Sep;55(3):595-606 - PubMed
  30. J Biol Chem. 1993 Jun 15;268(17):12341-7 - PubMed
  31. Int J Fertil Womens Med. 2000 May-Jun;45(3):236-40 - PubMed
  32. Chem Res Toxicol. 1995 Mar;8(2):284-91 - PubMed

Publication Types